More patent applications are rejected because of claim drafting flaws than because of problems with inventions. A trusted working tool for more than two decades
Examining the intersection between the statutory and regulatory scheme governing approval of generic pharmaceuticals and U.S. patent law in the context of Parag
Invention Analysis and Claiming presents a comprehensive approach to analyzing inventions and capturing them in a sophisticated set of patent claims. A central